SEATTLE, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), today announced the publication of the first human SPECT images ...

Left: primary/scatter window SPECT reconstructions, plus synthetic and CT-based attenuation maps. Right: SPECT reconstructed images corrected using CT-based attenuation maps, synthetic attenuation ...

SEATTLE, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), today announced the publication of the first human SPECT images ...

Image was selected as “Image of the Month” in the European Journal of Nuclear Medicine and Molecular Imaging, November 2023 “We are pleased to be able to provide our patients with Perspective’s novel ...